Kiniksa - KNSA Balans kapitallashuvi
Kiniksa Pharmaceuticals perikardit terapiyasiga bo'lgan barqaror talab hisobiga barqaror pul oqimini saqlab qolmoqda. Kompaniya og'ir yurak patologiyalari va yallig'lanishning ilg'or davolash vositalarini sotish orqali daromad keltiradi. GURU.Markets platformasidagi ushbu narxlar grafigi, bunda ko'rsatkich 0.41 darajasida turibdi, dori ishlab chiqarishga moslashuvchan yondashuv va opsionlar tizimi orqali yetakchi mutaxassislarni jalb qilayotgan avtoimmun dori ishlab chiquvchining profilini to'ldiradi.
%20Kompaniyaning%20balans%20qiymati&width=1200&height=400&colorIndex=0&v=mvrk6wqv.ssk-7as46ww&start=20220704&end=20261028&filename=GURU_Markets_-_KNSA_-_Kiniksa-Pharmaceuticals_-_Company-Book-Value "Kiniksa Pharmaceuticals, Ltd. (KNSA): Sof aktivlar qiymati 04.07.2022dan 28.10.2026gacha | 👁️GURU.Markets👁️")
Kiniksa (KNSA) kompaniyasi koʻrsatkichlari kesimi va tahlili
- narx va narxlar bo'yicha konsensus prognoz:
- bozor kapitallashuvi bo'yicha ma'lumotlar:
- balans kapitallashuvi bo'yicha ma'lumotlar:
- qarz va likvidlik bo'yicha ma'lumotlar:
Umumiy qarzning kapitalga nisbati Kiniksa Pharmaceuticals|KNSA - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzdorlikning kapitalga nisbati Kiniksa Pharmaceuticals, Ltd.|KNSA - Kompaniya qarzlari|Qarzning balans qiymatiga nisbati Kiniksa Pharmaceuticals, Ltd.|KNSA - Kompaniyaning uzoq muddatli qarzlari|Kompaniyaning qisqa muddatli qarzlari Kiniksa
Fundamental baholash:KNSA - Kiniksa Corp
Noyob patologiyalar uchun immunoterapiya sohasida monopol niche’larni ishlab chiqayotgan Kiniksa Pharmaceuticals (KNSA) uchun ushbu ko'rsatkich R&D ni kengaytirish uchun mavjud aktivlarning real qiymatini o'lchov birligi bo'lib xizmat qiladi. Kapitalning joriy balans qiymatini tahlil qilish bozor narxi va sof aktivlar o'rtasidagi farqni baholash imkonini beradi, bu esa investorga real vaqt rejimida baholash orqali kompaniyaning intellektual salohiyati uchun qanchalik ortiqcha to'lov qilinganini aniqlashga yordam beradi.
Kiniksa Pharmaceuticals raqobatchilari tahlili
ARGX - Biznesning balans bahosi|BNTX: Balans kapitallashuvi|ABVX (ABIVAX) - Balans kapitallashuvi|Kompaniyaning balans qiymati ADMA Biologics, Inc. ADMA|Sof aktivlar qiymati Protagonist Therapeutics, Inc.|Immunovant Corp (IMVT) - Balans kapitallashuvi|Kompaniyaning buxgalteriya qiymati Grifols Biemat (GRFS)|Balans kapitallashuvi ADPT (Adaptive Biotechnologies)|celldex.com - Balans kapitallashuvi|Kompaniyaning balans qiymati Aurinia Pharmaceuticals Inc. (AUPH)|BCRX: Kompaniyaning buxgalteriya qiymati|VERA (Vera Pharma) - Kompaniyaning balans qiymati|Dianthus Corp (DNTH) - Kompaniyaning sof aktivlari|PHVS (Pharvaris N.V.) - Balans kapitallashuvi|Balans kapitallashuvi AbCellera Corp (ABCL)|Tourmaline Bio (TRML) - Kompaniyaning sof aktivlari|Kompaniyaning buxgalteriya qiymati Precigen Inc (PGEN)|Balans kapitallashuvi PHAR|Nektar Corp - Biznesning balans bahosi|UPB: Kompaniyaning balans qiymati|ZBIO: Kompaniyaning sof aktivlari|IMNM (Immunome) - Kompaniyaning balans qiymati|Kompaniyaning sof aktivlari Gossamer Bio Inc|KALV (KalVista Pharmaceuticals Inc) - Kompaniyaning sof aktivlari|Balans kapitallashuvi SEPN|Kompaniyaning balans qiymati Pieris Pharmaceuticals PVLA|Buxgalteriya kapitallashuvi savarapharma.com (SVRA)|RIGL: Balans kapitallashuvi|AnaptysBio Inc - Kompaniyaning xususiy kapitali|Astria Pharma - Kompaniyaning balans qiymati|ENGN - Balans kapitallashuvi|RAPT Therapeutics, Inc. - Balans kapitallashuvi|JBIO (Aerovate Therapeutics) - Biznesning balans bahosi|Kompaniyaning balans qiymati Aclaris Therapeutics, Inc. (ACRS)|Buxgalteriya kapitallashuvi Kyverna Therapeutics Inc.|TLSA (Tiziana Life Sciences PLC) - Balans kapitallashuvi|Biznesning balans bahosi CABA (Cabaletta Bio Inc)|Kompaniyaning balans qiymati VTYX (Ventyx Biosciences)|theratech.com - Balans kapitallashuvi|Kompaniyaning balans qiymati AVTX (Avalo Therapeutics)|ELDN - Biznesning balans bahosi|AGEN: Balans kapitallashuvi|Balans kapitallashuvi Climb Bio, Inc|ZURA - Kompaniyaning sof aktivlari|Kompaniyaning buxgalteriya qiymati ATYR|ADAG - Kompaniyaning balans qiymati|Sof aktivlar qiymati ikenaoncology.com (IMA)|Balans kapitallashuvi Shattuck Labs|Kompaniyaning buxgalteriya qiymati Equillium Inc EQ|Connect Pharma - Balans kapitallashuvi|IMUX: Balans kapitallashuvi|Kompaniyaning balans qiymati atarabio.com ATRA|IFRX (InflaRx) - Kompaniyaning buxgalteriya qiymati|Kompaniyaning balans qiymati XFOR|Kompaniyaning sof aktivlari Adicet|Balans kapitallashuvi CELU|Balans kapitallashuvi inmunebio.com (INMB)|Barinthus Biotherapeutics plc - Balans kapitallashuvi|Kompaniyaning sof aktivlari Kezar Life Sciences Inc. KZR|SABS (SAB Biotherapeutics, Inc) - Balans kapitallashuvi|Akari Therapeutics, Plc (AKTX) - Kompaniyaning xususiy kapitali|ENLV: Kompaniyaning sof aktivlari|Balans kapitallashuvi Q32 Bio|GeoVax (GOVX) - Kompaniyaning sof aktivlari|Jami sof aktivlar Edesa Biotech Inc|IBIO (iBio Corp) - Balans kapitallashuvi|Biznesning balans bahosi carismatx.com (CARM)|XTL Biopharmaceuticals - Balans kapitallashuvi|Kompaniyaning sof aktivlari Bolt Biotherapeutics Inc. BOLT|HCW Biologics Inc - Balans kapitallashuvi|APVO: Balans kapitallashuvi|AIM ImmunoTech (AIM) - Kompaniyaning balans qiymati|ADTX (Aditxt, Inc.) - Kompaniyaning balans qiymati|GRI: Kompaniyaning balans qiymati|Biznesning balans bahosi XRTX|Kompaniyaning balans qiymati HIND|Balans kapitallashuvi REVB (Revelation Biosciences Inc)|INDP - Kompaniyaning balans qiymati|BiondVax Pharmaceuticals - Buxgalteriya kapitallashuvi|Kompaniyaning balans qiymati CALI (CalciMedica Corp)|AFMD - Biznesning balans bahosi|ALLK: Balans kapitallashuvi|HOOK (HOOKIPA Pharma) - Balans kapitallashuvi|Kompaniyaning balans qiymati IGM Biosciences Inc. IGMS|Sof aktivlar qiymati iTeos Pharma|Ocean Biomedical, Inc. (OCEA) - Balans kapitallashuvi|Kompaniyaning buxgalteriya qiymati tcbiopharm.com (TCBP)|Balans kapitallashuvi THRD (Third Harmonic Bio, Inc.)